Treace Medical Concepts (TMCI) Enterprise Value (2020 - 2025)
Treace Medical Concepts (TMCI) has disclosed Enterprise Value for 5 consecutive years, with -$75.7 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Enterprise Value rose 38.57% year-over-year to -$75.7 million, compared with a TTM value of -$75.7 million through Dec 2024, up 38.57%, and an annual FY2024 reading of -$75.7 million, up 38.57% over the prior year.
- Enterprise Value was -$75.7 million for Q4 2024 at Treace Medical Concepts, up from -$82.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$10.3 million in Q2 2020 and bottomed at -$123.2 million in Q4 2023.
- Average Enterprise Value over 5 years is -$67.4 million, with a median of -$82.0 million recorded in 2022.
- The sharpest move saw Enterprise Value tumbled 1060.81% in 2021, then soared 88.15% in 2023.
- Year by year, Enterprise Value stood at -$18.1 million in 2020, then plummeted by 485.39% to -$105.8 million in 2021, then grew by 23.23% to -$81.3 million in 2022, then crashed by 51.62% to -$123.2 million in 2023, then surged by 38.57% to -$75.7 million in 2024.
- Business Quant data shows Enterprise Value for TMCI at -$75.7 million in Q4 2024, -$82.8 million in Q3 2024, and -$18.2 million in Q2 2024.